Ontology highlight
ABSTRACT: Purpose
Obesity and metabolic syndrome are acknowledged as key factors contributing to the development of non-alcoholic fatty liver disease (NAFLD). Vitamin D (VitD) is a multifaceted secosteroid hormone known for its anti-fibrotic and anti-inflammatory properties, with its deficiency often linked to obesity. Our study aimed to investigate whether VitD supplementation could mitigate the liver pathology associated with NAFLD.Materials and methods
The NAFLD model was developed by subjecting male C57BL/6 mice to a high-fat diet (HFD) for 14 weeks. These mice were supplemented with VitD through intraperitoneal injection at a dosage of 7 µg/kg, administered three times per week for 7 weeks.Results
HFD resulted in VitD deficiency, insulin resistance, and increased liver w
SUBMITTER: Chung SI
PROVIDER: S-EPMC11790407 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature